Mirina Raises Series A-1 Round

Mirina Corp., a Seattle-based developer of microRNA therapeutics, has raised an undisclosed amount of Series A-1 funding. Versant Ventures led the round, and was joined by return backers Alexandria Real Estate Equities, ARCH Venture Partners, OVP Venture Partners and WRF Capital. The company had raised a $3.6 million Series A round in 2008.

North AmericaUSBriefs